WEISNER AIMEE S — SEC insider filings
SEC reporting owner CIK 1227308. 37 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 37 filings on record, filed 2021-01-06 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 53,750 shares, $295,400 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 40,000 shares, $4,760,761 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
- Largest priced transaction: sale of 25,000 shares @ $120.00 ($3,000,000) in GLAUKOS Corp, filed 2024-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GLAUKOS Corp (GKOS) | Director | 17 | — | 5 legs · 40,000 sh · $4,760,761 | 27 |
| STAAR SURGICAL CO (STAA) | Director | 7 | 2 legs · 3,750 sh · $164,132 | — | 5 |
| LENSAR, Inc. (LNSR) | Director | 10 | 4 legs · 50,000 sh · $131,268 | — | 10 |
| Oyster Point Pharma, Inc. (OYST) | Director | 3 | — | — | 8 |
Insider filings — WEISNER AIMEE S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | GLAUKOS Corp (GKOS) | Gift (G): 2,382 @ $0 · Gift (G): 2,382 @ $0 | EDGAR |
| 2026-06-23 | 4/A | GLAUKOS Corp (GKOS) | Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 17,421 @ $0 | EDGAR |
| 2026-06-01 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,878 @ $0 · Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | GLAUKOS Corp (GKOS) | Gift (G): 980 @ $0 · Gift (G): 980 @ $0 · Option exercise (M): 15,000 @ $24.69 · Sale (S): 2,153 @ $115.69 · Sale (S): 5,242 @ $116.64 · Sale (S): 1,134 @ $117.33 · +2 more | EDGAR |
| 2026-01-07 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 623 @ $0 | EDGAR |
| 2025-06-02 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 461 @ $0 · Grant/award (A): 2,108 @ $0 · Grant/award (A): 3,149 (derivative) @ $0 | EDGAR |
| 2025-05-28 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 7,374 @ $0 | EDGAR |
| 2024-08-12 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 25,000 @ $32 · Sale (S): 25,000 @ $120 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 4,488 @ $0 | EDGAR |
| 2024-06-03 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,716 @ $0 · Grant/award (A): 1,246 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 22,000 @ $0 | EDGAR |
| 2024-03-14 | 4 | STAAR SURGICAL CO (STAA) | Purchase (P): 1,750 @ $38.11 | EDGAR |
| 2024-01-04 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 895 @ $0 | EDGAR |
| 2024-01-02 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 3,200 @ $31.21 | EDGAR |
| 2023-10-03 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 497 @ $40.18 | EDGAR |
| 2023-08-07 | 4 | STAAR SURGICAL CO (STAA) | Purchase (P): 2,000 @ $48.72 | EDGAR |
| 2023-06-16 | 4 | STAAR SURGICAL CO (STAA) | Option exercise (M): 3,417 @ $0 | EDGAR |
| 2023-06-05 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 3,230 @ $0 | EDGAR |
| 2023-05-30 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 9,288 @ $0 · Grant/award (A): 33,175 (derivative) @ $0 | EDGAR |
| 2023-05-23 | 4 | LENSAR, Inc. (LNSR) | Purchase (P): 16,647 @ $2.75 | EDGAR |
| 2023-05-19 | 4 | LENSAR, Inc. (LNSR) | Purchase (P): 3,500 @ $2.29 · Purchase (P): 7,700 @ $2.61 · Purchase (P): 22,153 @ $2.59 | EDGAR |
| 2023-03-10 | 4 | GLAUKOS Corp (GKOS) | Option exercise (M): 10,000 @ $7.28 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,572 @ $0 | EDGAR |
| 2023-01-04 | 4 | Oyster Point Pharma, Inc. (OYST) | Disposition to issuer (D): 33,191 · Disposition to issuer (D): 3,573 · Disposition to issuer (D): 5,359 (derivative) · Disposition to issuer (D): 5,199 (derivative) | EDGAR |
| 2022-06-17 | 4 | STAAR SURGICAL CO (STAA) | Option exercise (M): 5,765 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Oyster Point Pharma, Inc. (OYST) | Grant/award (A): 3,573 @ $0 · Grant/award (A): 5,359 (derivative) @ $0 | EDGAR |
| 2022-06-06 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 4,364 @ $0 | EDGAR |
| 2022-05-27 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 4,285 @ $0 · Grant/award (A): 15,616 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,455 @ $0 | EDGAR |
| 2021-08-09 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 2,000 @ $51.66 | EDGAR |
| 2021-06-09 | 4 | Oyster Point Pharma, Inc. (OYST) | Grant/award (A): 3,466 @ $0 · Grant/award (A): 5,199 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 2,382 @ $0 | EDGAR |
| 2021-05-20 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 20,847 (derivative) @ $0 | EDGAR |
| 2021-03-16 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 13,445 (derivative) @ $0 | EDGAR |
| 2021-02-02 | 4 | LENSAR, Inc. (LNSR) | Grant/award (A): 28,249 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 980 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1227308 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs